Anti-HGFR/c-Met Antibody (Onartuzumab)
Catalog No.
F2040
Anti-HGFR/c-Met Antibody (Onartuzumab)
Featured Products
Onartuzumab (MetMAb) is a humanized affinity-matured monovalent monoclonal antibody that inhibits the receptor tyrosine kinase MET. Onartuzumab can effectively inhibit HGF binding, receptor phosphorylation and signal transduction. Onartuzumab has antibody-like pharmacokinetics and antitumor activity.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
99.51 kDa
Dry ice
1133766-06-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
MetMAb, PRO143966, RG3638
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P08581
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
HGFR / c-Met
Please avoid freeze-thaw cycles.